Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
2022-01-27 5:13 pm Unchanged | 13G | NEVRO CORP NVRO | BlackRock Inc. BLK | 4,150,231 11.9% | 0 (Unchanged) | View |
2022-01-26 09:16 am Purchase | 13G | NEVRO CORP NVRO | BlackRock Inc. BLK | 4,150,231 11.9% | 428,381 (+11.51%) | View |
2022-01-10 2:12 pm Sale | 13G | NEVRO CORP NVRO | PRICE T ROWE ASSOCIATES INC | 2,328,531 6.6% | -1,699,789 (-42.20%) | View |
2021-09-10 4:11 pm Sale | 13G | NEVRO CORP NVRO | ALGER ASSOCIATES INC | 1,241,415 3.56% | -895,197 (-41.90%) | View |
2021-02-16 4:54 pm Purchase | 13G | NEVRO CORP NVRO | ALGER ASSOCIATES INC | 2,136,612 6.21% | 222,654 (+11.63%) | View |
2021-02-16 4:04 pm Sale | 13G | NEVRO CORP NVRO | D. E. SHAW & CO L.P. | 1,099,450 3.2% | -833,068 (-43.11%) | View |
2021-02-16 12:23 pm Purchase | 13G | NEVRO CORP NVRO | PRICE T ROWE ASSOCIATES INC | 4,028,320 11.7% | 278,124 (+7.42%) | View |
2021-02-12 4:10 pm Sale | 13G | NEVRO CORP NVRO | HealthCor Management L.P. | 156,046 0.5% | -1,591,574 (-91.07%) | View |
2021-02-10 11:28 am Purchase | 13G | NEVRO CORP NVRO | VANGUARD GROUP INC | 3,100,236 9% | 354,127 (+12.90%) | View |
2021-01-26 6:52 pm Purchase | 13G | NEVRO CORP NVRO | BlackRock Inc. BLK | 3,721,850 10.8% | 260,101 (+7.51%) | View |
2020-07-10 10:39 am Purchase | 13G | NEVRO CORP NVRO | BlackRock Inc. BLK | 3,461,749 10.2% | 733,926 (+26.91%) | View |
2020-03-27 07:00 am Purchase | 13G | NEVRO CORP NVRO | HealthCor Management L.P. | 1,747,620 5.5% | 1,747,620 (New Position) | View |
2020-03-10 1:10 pm Purchase | 13G | NEVRO CORP NVRO | PRICE T ROWE ASSOCIATES INC | 3,750,196 11.7% | 1,067,358 (+39.78%) | View |
2020-02-14 4:40 pm Sale | 13G | NEVRO CORP NVRO | ArrowMark Colorado Holdings LLC | 574,026 1.85% | -1,212,497 (-67.87%) | View |
2020-02-14 4:26 pm Sale | 13G | NEVRO CORP NVRO | D. E. SHAW & CO L.P. | 1,932,518 6.2% | -183,706 (-8.68%) | View |
2020-02-14 1:30 pm Sale | 13G | NEVRO CORP NVRO | PRICE T ROWE ASSOCIATES INC | 2,682,838 8.6% | -395,776 (-12.86%) | View |
2020-02-14 11:00 am Purchase | 13G | NEVRO CORP NVRO | ALGER ASSOCIATES INC | 1,913,958 6.17% | 1,913,958 (New Position) | View |
2020-02-12 08:09 am Purchase | 13G | NEVRO CORP NVRO | VANGUARD GROUP INC | 2,746,109 8.85% | 136,538 (+5.23%) | View |
2020-02-07 4:59 pm Sale | 13G | NEVRO CORP NVRO | INTEGRATED CORE STRATEGIES (US) LLC | 207,173 0.7% | -1,363,876 (-86.81%) | View |
2020-02-05 1:58 pm Sale | 13G | NEVRO CORP NVRO | FRANKLIN RESOURCES INC BEN | 1,332,644 4.3% | -704,272 (-34.58%) | View |